|
Market Cap (5-Jun) $55,535,856 (1,270th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 227,504 |
Shortsold (18-Aug) 146,107 (0.01%) (520th) |
|
52w High $0.045 |
52w Low $0.040 |
P/E - |
EPS 0.03 |
DNA released this announcement to the ASX on 18 February 2021, 14:37. The announcement is not marked as price sensitive, and is 1 page(s) in length and 152.25kb in size.
You can view all announcements from DNA and see how they appear on a price chart on the announcements page.
At the date of this announcement, DNA was 0.012% short sold according to ASIC data. It was ranked the 520th most shorted stock on the ASX. It remains ranked 520th as of the latest reported data (18 August 2025).
| Other Recent Announcements from DNA | |
|---|---|
| Quarterly Activities Report | 28 April 2023, 16:17 |
| Appendix 4C Cash Flow Report | 28 April 2023, 16:15 |
| 1H FY23 Results Summary | 1 March 2023, 8:45 |
| 1H FY21 Results Investor Briefing | 18 February 2021, 14:37 |
| Change of Director's Interest Notice | 1 February 2021, 8:58 |
| Quarterly Activities Report & Appendix 4C - 31 December 2020 | 29 January 2021, 10:04 |
| Donaco completes Star Vegas settlement | 11 January 2021, 17:09 |
You must be logged in to post a reply.
Donaco International 